← brief for 2026-10-20 · Slowing decline

Exploring heterogeneous treatment effects for GLP-1 receptor agonists in patients with type 2 diabetes.

Article C Peer reviewed Observational

Key takeaways

This study looked at how different people respond to GLP-1 drugs for type 2 diabetes. It found that some people get much better results than others. The study uses data from past records, so it shows a link between patient traits and drug response, not proof of cause. This helps doctors pick the right drug for the right person.

Who did this work

Keele L · Bonvini M · Storås AM · Shirvaikar V · Li H · Jørgensen NB · Salsali A · Medici M · Mertens A · Kvist K

Source

Article · PubMed, the drug frontier · 2026 Oct 20
https://pubmed.ncbi.nlm.nih.gov/42901472/